Recent news on Videx Ec

McGuinty Government Improves Access To Drugs  -  Dec 20, 2006
CNW Telbec (Communiqués de presse),Norprolac tablets (Hormone disorder) - Caduet tablets (Cardiovascular drug) - Videx EC (HIV/AIDS) - Tobi (Cystic Fibrosis) - Myfortic (Transplantation)

Triple nuke combination of AZT/3TC/tenofovir below current ...  -  Dec 17, 2006
Aidsmap,Despite reports emerging in 2003 that tenofovir/3TC in combination with abacavir (Ziagen) or ddI (didanosine, Videx/Videx EC) had a high rate of early

McGuinty Government Improves Access To Drugs  -  Dec 20, 2006
CNW Telbec (Communiqués de presse),Norprolac tablets (Hormone disorder) - Caduet tablets (Cardiovascular drug) - Videx EC (HIV/AIDS) - Tobi (Cystic Fibrosis) - Myfortic (Transplantation)

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI and ...  Jun 30, 2006
Individuals coinfected with HIV and hepatitis C virus (HCV) should use ddI (didanosine, Videx/Videx EC) and d4T (stavudine, Zerit) with caution, according to ... -Aidsmap

Better than expected 'real world' benefits seen in highly ...  Jun 22, 2006
2004. The nucleoside background combination was similar to the 045 study, with two-thirds on tenofovir (Viread) and ddI (Videx EC). ... -Aidsmap



Next generation NRTI, DFC (formerly Reverset) discontinued to due ...  11 Apr 2006
Study 203 had found that a combination of DFC with ddI (didanosine, Videx/Videx EC led to a 50% incidence rate of grade 4 hyperlipasaemia, with seven of the 14 ... - Aidsmap



Multi-component drug delivery system: An emerging trend  Feb 8, 2006
...abacavir/lamivudine /zidovudine (Trizivir), lamivudine/zidovudine (Combivir), stavudine, d4T (Zerit), didanosine, ddI (Videx, Videx EC), zalcitabine, ddC (HIVID ... - Express Pharma Pulse,

Multi-component drug delivery system: An emerging trend  Feb 8, 2006
...abacavir/lamivudine /zidovudine (Trizivir), lamivudine/zidovudine (Combivir), stavudine, d4T (Zerit), didanosine, ddI (Videx, Videx EC), zalcitabine, ddC (HIVID ... - Express Pharma Pulse

Simplified treatment regimens show promise in HIV-infected ...  Feb 6, 2006
They treated the patients with a once-daily regimen of three anti-HIV drugs comprising ddI (didanosine, Videx / Videx EC), FTC (emtricitabine, Emtriva) and ... - Aidsmap

Bristol-Myers Squibb Company Reports Financial Results for the ...  Jan 25, 2006
32)% 3 9 (67)% (57)% Virology Reyataz 188 148 27% 110 99 11% 25% Sustiva 170 172 (1)% 102 103 (1)% 5% Zerit 47 67 (30)% 21 31 (32)% (32)% Videx/Videx EC 41 67 ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional